11 Nov 2015
Findings from a large clinical trial known as EMPA-REG OUTCOME were reported at the American Heart Association annual conference; they demonstrate for the first time that a type-2 diabetes drug, Jardiance, reduces risk of heart failure.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024